Here are four updates on GI companies from the past week:
Exact Sciences broke ground on a 138,000-square-foot headquarters in Madison, Wis., to unite a portion of its workforce.
Pfizer and Exact Sciences teamed up to co-promote Cologuard through 2021.
Provation added an automated adenoma detection rate feature to Provation MD, its procedure documentation and coding software.
Creo Medical Group raised about $63 million (£48.5 million) in funding after selling 38.8 million new shares.
More articles in gastroenterology:
5 big challenges for gastroenterologists + why to consider a cash-pay model
Assemblymember Victor Pichardo visits Mid-Bronx Endoscopy Center — 3 insights
ASGE offers 4 activities to meet MIPS requirement — 4 things to know